IDEAS home Printed from https://ideas.repec.org/p/pra/mprapa/101695.html
   My bibliography  Save this paper

Economics of Insulin Device vs Conventional Vial and Syringe

Author

Listed:
  • Baser, Onur
  • Bouchard, Jonathan
  • DeLuzio, Tony
  • Henk, Henry
  • Aagren, Mark

Abstract

Introduction: Diabetes is difficult to manage and treatment involves significant lifestyle adjustments. Unlike the traditional method of insulin administration via the vial and syringe method, insulin pens might be perceived as less cumbersome and have potential to significantly increase patient adherence. Methods: Using “real world” data, we examined the differences in adherence and costs between diabetic patients using an insulin FlexPen® (Novo Nordisk Inc, Princeton, NJ, USA) and those using traditional vial and syringe administration. Using a retrospective analysis of health insurance claims data between the years 2003 and 2008, we examined patients in the FlexPen cohort and analog vial cohort. Propensity score matching was used to match these cohorts (n=532 in each) according to baseline characteristics. Results: Adjusted mean medication possession ratio when switched to FlexPen improved by 22 percentage points versus 13 percentage points when continuing to use vials (P=0.001). Diabetes- related healthcare costs when switched to FlexPen versus continuing on to use vials ($3970 vs. $4838, respectively, P=0.9368) and total healthcare costs ($13,214 vs. $13,212, respectively, P=0.9473) were not statistically different. Conclusion: Without significant addition to the cost, insulin administration with FlexPen is associated with an improved adherence among patients who switched from vial-based insulin administration.

Suggested Citation

  • Baser, Onur & Bouchard, Jonathan & DeLuzio, Tony & Henk, Henry & Aagren, Mark, 2010. "Economics of Insulin Device vs Conventional Vial and Syringe," MPRA Paper 101695, University Library of Munich, Germany.
    • Handle: RePEc:pra:mprapa:101695
    as

    Download full text from publisher

    File URL: https://mpra.ub.uni-muenchen.de/101695/1/MPRA_paper_101695.pdf
    File Function: original version
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    adherence; costs; FlexPen; insulin; real world; syringe;
    All these keywords.

    JEL classification:

    • C0 - Mathematical and Quantitative Methods - - General
    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pra:mprapa:101695. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Joachim Winter (email available below). General contact details of provider: https://edirc.repec.org/data/vfmunde.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.